Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trialDiana Crivellari, Aron Goldhirsch, Silvia Dellapasqua et al.|The Breast|2013Cited by 56